H. Lundbeck A/S Mutual Funds

Health Care & Life Sciences » Pharmaceuticals | H. Lundbeck A/S

H. Lundbeck A/S | Mutual Funds

Mutual Funds that own H. Lundbeck A/S

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Government Pension Fund - Global (The)

2,213,822

1.11%

1,030,660

0.02%

12/31/2017

Oppenheimer International Small Company Fund

2,202,524

1.11%

1.23%

02/28/2018

Oppenheimer Global Opportunities Fund

2,000,000

1.26%

03/31/2018

Vanguard Health Care Fund

1,544,589

0.78%

-782,548

0.18%

06/30/2018

Invesco Funds - Pan European Structured Equity Fund

1,427,110

0.72%

496,377

1.27%

03/29/2018

Vanguard Total International Stock Index Fund

856,716

0.43%

23,054

0.01%

07/31/2018

Stichting Pensioenfonds ABP (Global Equity Portfolio)

834,452

0.42%

383,812

0.01%

03/31/2018

Deutsche Quant Equity Low Volatility Europe

739,720

0.37%

-17,264

1.36%

07/31/2018

ATP Group Portfolio

646,032

0.32%

-551,604

0.03%

12/31/2017

iShares MSCI EAFE Minimum Volatility ETF

581,314

0.28%

4,884

0.39%

09/06/2018

About H. Lundbeck A/S

View Profile

Address	Ottiliavej 9 Valby CR 2500 Denmark
Employees	-
Website	http://www.lundbeck.com
Updated	07/08/2019
H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders. It operates through the following geographical segments: Europe, the Unites States of America, and International Markets.